Skip to content

Use of varanadi kashayam and chitrakadi nasal drops in nasal polyp

EFFECT OF VARANADIGANA KASHAYAPANAM AND CHITRAKADIARKA PRATIMARSHA NASYAM IN ETHMOIDAL POLYPOSIS - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082392
Enrollment
22
Registered
2025-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J330- Polyp of nasal cavity

Interventions

None listed

Sponsors

Nimisha ap
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed of ethmoidal nasal polyposis based on signs and symptoms. 2.Age group 20-60 years irrespective of sex. 3.Patients with written informed consent

Exclusion criteria

Exclusion criteria: a)Antrochoanal polyps b)Painful and infectious polyps c)Rhinosporidiosis d)Nosebleeds and orbital symptoms related to polyps e)Cases where immediate surgical procedures are required f)People who suffer from bronchial asthma g)Those who are contra indicated for Pratimarshanasyam h)Patients with bleeding diseases and severe debilitating diseases. i)Patients with uncontrolled diabetes and hypertension

Design outcomes

Primary

MeasureTime frame
NASAL BLOCKAGE Timepoint: 0th,15th, 31st and 46th days

Secondary

MeasureTime frame
To assess efficacy of Varanadigana Kashaya and Chitrakadi Arka in reducing the size of ethmoidal polyposis. Timepoint: 0th,15th,31st day

Countries

India

Contacts

Public ContactDr Kusumam Joseph

GOVERNMENT AYURVEDA MEDICAL COLLEGE THIRUVANANTHAPURAM

nimishasuresh01997@gmail.com8157913285

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026